Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Remifentanil in Preventing Emergence Agitation in Patients Undergoing Nasal Surgery Under Desflurane Anesthesia: A Prospective Double-blind Randomized Controlled Trial.

NCT06539013 is registered in ClinicalTrials.gov with Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital as lead sponsor.

NCT NCT06539013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06539013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Remifentanil in Preventing Emergence Agitation in Patients Undergoing Nasal Surgery Under Desflurane Anesthesia: A Prospective Double-blind Randomized Controlled Trial.
Lead sponsor
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
August 1, 2024
Completion date
October 1, 2024
Enrollment
99 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

emergence agitation